Research progress of post-acute sequelae after SARS-CoV-2 infection

T Jiao, Y Huang, H Sun, L Yang - Cell Death & Disease, 2024 - nature.com
SARS-CoV-2 has spread rapidly worldwide and infected hundreds of millions of people
worldwide. With the increasing number of COVID-19 patients discharged from hospitals, the …

Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19

S Chen, C Zhang, D Chen, L Dong, T Chang… - Frontiers in …, 2023 - frontiersin.org
Nowadays, people have relaxed their vigilance against COVID-19 due to its declining
infection numbers and attenuated virulence. However, COVID-19 still needs to be concern …

Predictive models of long COVID

B Antony, H Blau, E Casiraghi, JJ Loomba… - …, 2023 - thelancet.com
Background The cause and symptoms of long COVID are poorly understood. It is
challenging to predict whether a given COVID-19 patient will develop long COVID in the …

Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis

S Tyagi, A Kumar - Critical Reviews in Oncology/Hematology, 2024 - Elsevier
Background The exact safety profile of Immune checkpoint inhibitors (ICIs) is unclear so far.
Aim The aim of the current study is to analyse the safety profile of ICIs in cancer patients …

Prevalence of poor sleep quality in COVID-19 patients: a systematic review and meta-analysis

Z Gui, YY Wang, JX Li, XH Li, Z Su, T Cheung… - Frontiers in …, 2024 - frontiersin.org
Objective The coronavirus disease (COVID-19) and the public health responses were
associated with a huge health burden, which could influence sleep quality. This meta …

Corticosteroids use for COVID-19: An overview of systematic reviews

M Cruciani, I Pati, F Masiello, S Pupella… - Le Infezioni in …, 2022 - pmc.ncbi.nlm.nih.gov
Purpose A reappraisal of the validity of the conclusions of systematic reviews (SRs) and
meta-analyses related to corticosteroids use for the treatment of COVID-19. Material and …

Effect of glucocorticoids on the development of COVID‐19‐associated pulmonary aspergillosis: A meta‐analysis of 21 studies and 5174 patients

Z Hashim, A Nath, A Khan, M Gupta, A Kumar… - Mycoses, 2023 - Wiley Online Library
Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) remains a high mortality
mycotic infection throughout the pandemic, and glucocorticoids (GC) may be its root cause …

Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India

A Sajgure, A Kulkarni, A Joshi, V Sajgure… - The Lancet Regional …, 2023 - thelancet.com
Background Antivirals and immunosuppressive agents are used with variable success in the
treatment of COVID-19. Mycophenolate, an inhibitor of enzyme inosine monophosphate …

Use of first-line oral analgesics during and after COVID-19: results from a survey on a sample of Italian 696 COVID-19 survivors with post-acute symptoms

V Galluzzo, MB Zazzara, F Ciciarello, M Tosato… - Journal of Clinical …, 2023 - mdpi.com
Highlights What are the main findings of the study? The most-used pain medication during
COVID-19 is acetaminophen. The most common analgesics used in post-COVID-19 are …